the royal medical foundation
the royal medical foundation Company Information
Company Number
04010652
Next Accounts
Mar 2026
Shareholders
-
Group Structure
View All
Industry
Other social work activities without accommodation n.e.c.
Registered Address
epsom college, college road, epsom, surrey, KT17 4JQ
the royal medical foundation Estimated Valuation
Pomanda estimates the enterprise value of THE ROYAL MEDICAL FOUNDATION at £170.1k based on a Turnover of £286.4k and 0.59x industry multiple (adjusted for size and gross margin).
the royal medical foundation Estimated Valuation
Pomanda estimates the enterprise value of THE ROYAL MEDICAL FOUNDATION at £0 based on an EBITDA of £-67.6k and a 5.78x industry multiple (adjusted for size and gross margin).
the royal medical foundation Estimated Valuation
Pomanda estimates the enterprise value of THE ROYAL MEDICAL FOUNDATION at £29.8m based on Net Assets of £9.9m and 3.02x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Royal Medical Foundation Overview
The Royal Medical Foundation is a live company located in epsom, KT17 4JQ with a Companies House number of 04010652. It operates in the other social work activities without accommodation n.e.c. sector, SIC Code 88990. Founded in June 2000, it's largest shareholder is unknown. The Royal Medical Foundation is a mature, micro sized company, Pomanda has estimated its turnover at £286.4k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Royal Medical Foundation Health Check
Pomanda's financial health check has awarded The Royal Medical Foundation a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
5 Weak
Size
annual sales of £286.4k, make it smaller than the average company (£481k)
£286.4k - The Royal Medical Foundation
£481k - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a similar rate (6.6%)
5% - The Royal Medical Foundation
6.6% - Industry AVG
Production
with a gross margin of 74.4%, this company has a comparable cost of product (74.4%)
74.4% - The Royal Medical Foundation
74.4% - Industry AVG
Profitability
an operating margin of -23.6% make it less profitable than the average company (3.5%)
-23.6% - The Royal Medical Foundation
3.5% - Industry AVG
Employees
with 2 employees, this is below the industry average (13)
2 - The Royal Medical Foundation
13 - Industry AVG
Pay Structure
on an average salary of £31.5k, the company has a higher pay structure (£26k)
£31.5k - The Royal Medical Foundation
£26k - Industry AVG
Efficiency
resulting in sales per employee of £143.2k, this is more efficient (£41.9k)
£143.2k - The Royal Medical Foundation
£41.9k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - The Royal Medical Foundation
- - Industry AVG
Creditor Days
its suppliers are paid after 618 days, this is slower than average (5 days)
618 days - The Royal Medical Foundation
5 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - The Royal Medical Foundation
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (230 weeks)
0 weeks - The Royal Medical Foundation
230 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1.3%, this is a lower level of debt than the average (13%)
1.3% - The Royal Medical Foundation
13% - Industry AVG
THE ROYAL MEDICAL FOUNDATION financials
The Royal Medical Foundation's latest turnover from June 2024 is £286.4 thousand and the company has net assets of £9.9 million. According to their latest financial statements, The Royal Medical Foundation has 2 employees and maintains cash reserves of £1.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 286,434 | 265,089 | 257,356 | 244,484 | 226,999 | 244,081 | 296,438 | 297,884 | 274,501 | 263,159 | 211,957 | 224,978 | 198,157 | 186,240 | 223,117 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | -63,278 | -75,576 | -890,282 | 1,320,942 | 9,662 | 205,805 | 88,098 | 100,758 | 37,439 | 32,996 | 37,821 | 77,813 | 62,143 | 43,668 | 79,796 |
| Tax | |||||||||||||||
| Profit After Tax | -63,278 | -75,576 | -890,282 | 1,320,942 | 9,662 | 205,805 | 88,098 | 100,758 | 37,439 | 32,996 | 37,821 | 77,813 | 62,143 | 43,668 | 79,796 |
| Dividends Paid | |||||||||||||||
| Retained Profit | -63,278 | -75,576 | -890,282 | 1,320,942 | 9,662 | 205,805 | 88,098 | 100,758 | 37,439 | 32,996 | 37,821 | 77,813 | 62,143 | 43,668 | 79,796 |
| Employee Costs | 63,035 | 57,640 | 57,936 | 77,384 | 75,932 | 71,177 | 70,930 | 67,206 | 68,617 | 77,846 | 75,067 | 70,779 | 70,236 | 83,090 | 67,565 |
| Number Of Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | 9,912,956 | 8,924,081 | 8,791,565 | 9,684,952 | 8,367,251 | 8,357,723 | 8,144,947 | 7,582,492 | 6,573,392 | 6,596,446 | 6,338,483 | 5,745,604 | 4,929,649 | 5,037,071 | 4,111,511 |
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 9,912,956 | 8,924,081 | 8,791,565 | 9,684,952 | 8,367,251 | 8,357,723 | 8,144,947 | 7,582,492 | 6,573,392 | 6,596,446 | 6,338,483 | 5,745,604 | 4,929,649 | 5,037,071 | 4,111,511 |
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | 103,204 | 12,071 | 104,520 | 70,869 | 24,485 | 67,942 | 55,119 | 33,028 | |||||||
| Misc Debtors | 10,960 | 14,000 | 14,000 | 14,000 | 14,000 | 14,351 | 4,412 | 4,352 | 2,240 | ||||||
| Cash | 1,814 | 162,222 | 133,618 | 97,416 | 64,662 | 35,661 | 52,816 | 105,900 | 118,219 | 6,383 | 33,037 | 73,025 | 2,867 | 7,738 | 18,502 |
| misc current assets | |||||||||||||||
| total current assets | 115,978 | 188,293 | 147,618 | 111,416 | 78,662 | 50,012 | 57,228 | 110,252 | 120,459 | 110,903 | 103,906 | 97,510 | 70,809 | 62,857 | 51,530 |
| total assets | 10,028,934 | 9,112,374 | 8,939,183 | 9,796,368 | 8,445,913 | 8,407,735 | 8,202,175 | 7,692,744 | 6,693,851 | 6,707,349 | 6,442,389 | 5,843,114 | 5,000,458 | 5,099,928 | 4,163,041 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 124,303 | 126,784 | 63,029 | ||||||||||||
| Group/Directors Accounts | 32,387 | 25,581 | 54,631 | 2,248 | |||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 9,859 | 16,772 | 9,932 | 10,814 | 35,932 | 7,416 | 7,661 | 7,390 | 11,104 | 12,249 | 6,552 | 6,360 | 6,120 | 5,880 | 7,240 |
| total current liabilities | 134,162 | 175,943 | 98,542 | 65,445 | 35,932 | 7,416 | 7,661 | 9,638 | 11,104 | 12,249 | 6,552 | 6,360 | 6,120 | 5,880 | 7,240 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 134,162 | 175,943 | 98,542 | 65,445 | 35,932 | 7,416 | 7,661 | 9,638 | 11,104 | 12,249 | 6,552 | 6,360 | 6,120 | 5,880 | 7,240 |
| net assets | 9,894,772 | 8,936,431 | 8,840,641 | 9,730,923 | 8,409,981 | 8,400,319 | 8,194,514 | 7,683,106 | 6,682,747 | 6,695,100 | 6,435,837 | 5,836,754 | 4,994,338 | 5,094,048 | 4,155,801 |
| total shareholders funds | 9,894,772 | 8,936,431 | 8,840,641 | 9,730,923 | 8,409,981 | 8,400,319 | 8,194,514 | 7,683,106 | 6,682,747 | 6,695,100 | 6,435,837 | 5,836,754 | 4,994,338 | 5,094,048 | 4,155,801 |
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | 88,093 | 12,071 | -351 | 9,939 | 60 | 2,112 | -102,280 | 33,651 | 46,384 | -43,457 | 12,823 | 22,091 | 33,028 | ||
| Creditors | -2,481 | 63,755 | 63,029 | ||||||||||||
| Accruals and Deferred Income | -6,913 | 6,840 | -882 | -25,118 | 28,516 | -245 | 271 | -3,714 | -1,145 | 5,697 | 192 | 240 | 240 | -1,360 | 7,240 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 988,875 | 132,516 | -893,387 | 1,317,701 | 9,528 | 212,776 | 562,455 | 1,009,100 | -23,054 | 257,963 | 592,879 | 815,955 | -107,422 | 925,560 | 4,111,511 |
| cash flow from investments | 893,387 | -1,317,701 | -9,528 | -212,776 | -562,455 | -1,009,100 | 23,054 | -257,963 | |||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -32,387 | 6,806 | -29,050 | 54,631 | -2,248 | 2,248 | |||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | 989,232 | 178,172 | -29,050 | 54,631 | 421,062 | 901,849 | -49,792 | 226,267 | 561,262 | 764,603 | -161,853 | 894,579 | 4,076,005 | ||
| cash and cash equivalents | |||||||||||||||
| cash | -160,408 | 28,604 | 36,202 | 32,754 | 29,001 | -17,155 | -53,084 | -12,319 | 111,836 | -26,654 | -39,988 | 70,158 | -4,871 | -10,764 | 18,502 |
| overdraft | |||||||||||||||
| change in cash | -160,408 | 28,604 | 36,202 | 32,754 | 29,001 | -17,155 | -53,084 | -12,319 | 111,836 | -26,654 | -39,988 | 70,158 | -4,871 | -10,764 | 18,502 |
the royal medical foundation Credit Report and Business Information
The Royal Medical Foundation Competitor Analysis
Perform a competitor analysis for the royal medical foundation by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in KT17 area or any other competitors across 12 key performance metrics.
the royal medical foundation Ownership
THE ROYAL MEDICAL FOUNDATION group structure
The Royal Medical Foundation has no subsidiary companies.
Ultimate parent company
THE ROYAL MEDICAL FOUNDATION
04010652
the royal medical foundation directors
The Royal Medical Foundation currently has 10 directors. The longest serving directors include Dr Hywel Bowen Perkins (May 2006) and Mr Richard Bruce (Jan 2012).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Hywel Bowen Perkins | 72 years | May 2006 | - | Director | |
| Mr Richard Bruce | United Kingdom | 72 years | Jan 2012 | - | Director |
| Mrs Karen Thomas | 66 years | Apr 2014 | - | Director | |
| Dr Helena Blake | England | 72 years | Apr 2014 | - | Director |
| Mr Andrew Pianca | 74 years | Jan 2017 | - | Director | |
| Dr Jeremy Bolton | 81 years | Jan 2017 | - | Director | |
| Mr Timothy Davies | 72 years | Jan 2020 | - | Director | |
| Mr Martin Beames | 58 years | Jan 2020 | - | Director | |
| Revd Andrew Haviland | United Kingdom | 59 years | Jul 2024 | - | Director |
| Dr Mark Jenkins | 50 years | Oct 2024 | - | Director |
P&L
June 2024turnover
286.4k
+8%
operating profit
-67.6k
0%
gross margin
74.4%
-1.08%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
9.9m
+0.11%
total assets
10m
+0.1%
cash
1.8k
-0.99%
net assets
Total assets minus all liabilities
the royal medical foundation company details
company number
04010652
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
88990 - Other social work activities without accommodation n.e.c.
incorporation date
June 2000
age
25
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
June 2024
previous names
N/A
accountant
-
auditor
CROWE U K LLP
address
epsom college, college road, epsom, surrey, KT17 4JQ
Bank
ALLIED IRISH BANK (GB)
Legal Advisor
-
the royal medical foundation Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the royal medical foundation.
the royal medical foundation Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE ROYAL MEDICAL FOUNDATION. This can take several minutes, an email will notify you when this has completed.
the royal medical foundation Companies House Filings - See Documents
| date | description | view/download |
|---|
